HelmAnalyze
→
Helm
AnalyzeGet Started
← Back to search
EWNeutral

Edwards Lifesciences Corp

Helm AI

Edwards Lifesciences Corp (EW) currently trades at $81.71, reflecting a market cap of $47.46B, but faces challenges with a significant EPS growth decline of -73.77% despite a revenue growth of 6.00% year-over-year. The stock's P/E ratio stands at 44.52, which is high compared to the industry average, indicating overvaluation risks, especially after missing Q4 2025 earnings estimates by 12.05%.

Current Price
$81.71
+1.08%
Market Cap
$47.46B
P/E (TTM)
44.52
Revenue Growth YoY
6.00%
EPS Growth YoY
-73.77%
Current Ratio
3.72
Recommendation

Given the mixed performance and high valuation, maintaining a neutral stance on Edwards Lifesciences is prudent at this time.

Recent Headlines

Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $92

2026-04-06

Tired of AI and Oil? Buy the Robot.

2026-04-08

Powered by Helm Terminal — helmterminal.dev
helmterminal.dev
PrivacyTerms